NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $689,000 | -40.4% | 37,842 | +16.4% | 0.02% | -39.3% |
| Q2 2019 | $1,157,000 | -21.0% | 32,504 | -25.5% | 0.03% | -24.3% |
| Q1 2019 | $1,465,000 | -69.8% | 43,622 | -70.4% | 0.04% | -73.0% |
| Q4 2018 | $4,845,000 | -33.4% | 147,390 | +23.5% | 0.14% | -20.8% |
| Q3 2018 | $7,273,000 | +983.9% | 119,306 | +768.6% | 0.17% | +917.6% |
| Q2 2018 | $671,000 | +44.0% | 13,736 | +213.2% | 0.02% | +30.8% |
| Q1 2018 | $466,000 | -66.5% | 4,386 | -81.2% | 0.01% | -65.8% |
| Q4 2017 | $1,393,000 | +200.2% | 23,324 | +20.6% | 0.04% | +192.3% |
| Q3 2017 | $464,000 | +41.9% | 19,346 | +15.7% | 0.01% | +30.0% |
| Q2 2017 | $327,000 | +46.6% | 16,728 | +75.7% | 0.01% | +42.9% |
| Q1 2017 | $223,000 | +112.4% | 9,520 | +11.1% | 0.01% | +133.3% |
| Q4 2016 | $105,000 | – | 8,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |